
Rabefit 20mg Injection
Marketer
Marc Laboratories Pvt Ltd
Salt Composition
Rabeprazole (20mg)
Overview Rabefit 20mg Injection
Gastracid 20mg Injection is a medication that diminishes stomach acid production. It treats acid-related gastrointestinal disorders, including acid reflux, indigestion, peptic ulcers, and other conditions stemming from excessive acid. Gastracid 20mg Injection offers rapid symptom relief and is used prophylactically against stress ulcers in critically ill patients, and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous injection is administered by a healthcare professional only when deemed more appropriate than oral administration. Dosage and treatment duration are determined by your physician based on your condition and response. Optimal treatment involves smaller, more frequent meals, and avoiding caffeine, spicy, and fatty foods. Common side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While usually mild, persistent or bothersome symptoms warrant medical attention. Prolonged use (over one year) may increase bone fracture risk, particularly at higher doses. Discuss bone health strategies with your doctor, such as calcium and vitamin D supplementation. Hypomagnesemia (low magnesium) can occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmias. Your doctor may monitor your magnesium levels. Gastracid 20mg Injection is contraindicated for individuals with severe liver disease, those on HIV medications, those with prior allergic reactions to similar drugs, or existing osteoporosis. Pregnant or breastfeeding individuals should consult their physician before use. Alcohol should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Rabefit 20mg Injection
Managing acid reflux and peptic ulcers.
Major Benefits of Rabefit 20mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Rabefit 20mg Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Rabefit 20mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Rabefit 20mg Injection works:
Gastro-acid reduction is achieved by the proton pump inhibitor (PPI) Rabefit 20mg Injection. This decreases stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rabefit 20mg Injection and alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Rabefit 20mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Administering Rabefit 20mg Injection while breastfeeding carries a likely risk. Available human data indicates potential transfer to breast milk, posing a possible threat to the infant.
DrivingCONSULT YOUR DOCTOR
Rabefit 20mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Rabefit 20mg Injection poses no safety concerns for patients with renal impairment; dose modification is unnecessary.
LiverCAUTION
For individuals with severe hepatic impairment, administration of Rabefit 20mg Injection requires careful monitoring. Dosage modification of Rabefit 20mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Rabefit 20mg Injection :
Omit a Rabefit 20mg Injection dose? Seek your physician's advice.
Facts to Know About Rabefit 20mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
